Historical Evolution and Clinical Application of Classical Prescription Xiao Xumingtang
10.13422/j.cnki.syfjx.20220526
- VernacularTitle:经典名方小续命汤的历史沿革及临床应用考证
- Author:
Jin ZENG
1
;
Yu-ting YANG
1
;
Meng-lei WANG
1
;
Ping CHEN
1
;
Yan-mei SHENG
2
;
Yu-mei YAN
1
;
Ai-jun ZHANG
1
;
Hong-mei ZHU
1
;
Ying DAI
1
;
Zhu-jun YIN
1
;
Li LI
1
;
Yao-hua LI
3
;
Pu-yan LI
3
;
Jun-ning ZHAO
1
Author Information
1. Institute of Translational Pharmacology and Clinical Application， Sichuan Academy of Traditional Chinese Medicine（TCM）， Key Laboratory of Biological Evaluation of TCM Quality of National Administration of TCM， Sichuan Key Laboratory of Translational Medicine of TCM， Sichuan Authentic Medicine System Development Engineering Technology Research Center， Sichuan Authentic Medicine Formation Principle and Quality Evaluation Engineering Research Center， Chengdu 610041， China
2. School of Pharmacy， Chengdu University of TCM， Chengdu 611100， China
3. Qinghai Dimar Tibetan Medicine Pharmaceutical Co. Ltd.，Xining 810003，China
- Publication Type:Journal Article
- Keywords:
classical formula;
Xiao Xumingtang;
historical evolution;
clinical application
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2022;28(6):182-191
- CountryChina
- Language:Chinese
-
Abstract:
Xiao Xumingtang in The Catalogue of Famous Ancient Classics （The First Batch） issued by the National Administration of Traditional Chinese Medicine is derived from the Important Prescriptions Worth a Thousand Gold for Emergency （Bei Ji Qian Jin Yao Fang） written by SUN Si-miao in the Tang dynasty. The present study systematically explored the origin， development， historical evolution， and clinical application of Xiao Xumingtang. As revealed by the results， Xiao Xumingtang as well as its analogues are primary prescriptions indicated for apoplexy before the Tang and Song dynasties and serve as the benchmark for the treatment of apoplexy. After the Song dynasty， due to the changes in the understanding of the pathogenesis of apoplexy and the limitations of the understanding of Xiao Xumingtang， its clinical application to apoplexy gradually decreased. In modern times， it has been re-recognized and applied， during which its clinical applications have undergone great changes. Its clinical applications are extensive， involving a variety of diseases related to the brain and nervous systems， such as stroke and its sequelae， peripheral facial paralysis， rheumatoid arthritis， hypertension， and other diseases related to the motor nervous system. Its primary indications are stroke and its sequelae， followed by peripheral facial paralysis. Other new indications are gradually found. This study is expected to provide references for the clinical application of Xiao Xumingtang and the transformation of new drugs.
